Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jose Carlos Fernandez-Garcia.
Clinical Epigenetics | 2018
Daniel Castellano-Castillo; Sonsoles Morcillo; Mercedes Clemente-Postigo; Ana B. Crujeiras; Jose Carlos Fernandez-Garcia; Esperanza Torres; Francisco J. Tinahones
BackgroundLack of vitamin D (VD) has been associated with colorectal cancer (CRC). VD has anti-inflammatory effects and regulates several cellular pathways by means of its receptor, including epigenetic modifications. Adipose tissue dysfunction has been related to low-grade inflammation, which is related to diseases like cancer. The aim of this study was to explore the relationship between serum 25-hydroxyvitamin D (25(OH)D), adipose tissue gene expression of VD receptor (VDR), pro-inflammatory markers, and the epigenetic factor DNA methyltransferase 3a (DNMT3A) as well as VDR promoter methylation in CRC.MethodsBlood and visceral adipose tissue from 57 CRC and 50 healthy control subjects were collected. CRC subjects had lower serum 25(OH)D levels and higher VDR gene expression, and these were negatively correlated in the CRC group.ResultsAdipose tissue NFκB1, IL6, and IL1B gene expression were higher in the CRC subjects than in the control subjects. 25(OH)D correlated negatively with NFκB1 and CRP. In turn, CRP correlated positively with NFκB1, IL6, IL1B, and VDR gene expression as well as NFκB1 that correlated positively with IL6 and IL1B. DNMT3A mRNA was negatively correlated with serum 25(OH)D and positively correlated with VDR DNA methylation. VDR DNA methylation at position 4 had lower levels in the CRC group. Global NFκB1 methylation at dinucleotide 3 was lower in the CRC group.ConclusionOur results suggest that adipose tissue may be a key factor in CRC development. The low 25(OH)D levels and high adipose tissue VDR expression in CRC may, at least in part, mediate this relationship by modifying adipose tissue DNA methylation and promoting inflammation.
Endocrine | 2016
Fernando Fernández-Aranda; Zaida Agüera; Jose Carlos Fernandez-Garcia; Lourdes Garrido-Sánchez; Juan Alcaide-Torres; Francisco J. Tinahones; Cristina Giner-Bartolomé; Rosa M. Baños; Cristina Botella; Ausiàs Cebolla; Rafael de la Torre; José Manuel Fernández-Real; Francisco Ortega; Gema Frühbeck; Javier Gómez-Ambrosi; Roser Granero; Mohamed A. Islam; Susana Jiménez-Murcia; Salomé Tárrega; José M. Menchón; Ana B. Fagundo; Carolina Sancho; Xavier Estivill; Janet Treasure; Felipe F. Casanueva
18th European Congress of Endocrinology | 2016
Isabel Moreno-Indias; Wilfredo Oliva-Olivera; Daniel Castellano-Castillo; Said Lhamyani; Jose Carlos Fernandez-Garcia; María Isabel Queipo-Ortuño; Fernando Cardona-Diaz; Francisco J. Tinahones
18th European Congress of Endocrinology | 2016
Jose Carlos Fernandez-Garcia; Carmen Maria Cortes-Salazar; la Cruz-Troca Juan Jose de; Juan Garcia-Arnes; Pedro Aranda-Lara
18th European Congress of Endocrinology | 2016
Jose Carlos Fernandez-Garcia; Carmen Maria Cortes-Salazar
18th European Congress of Endocrinology | 2016
Jose Carlos Fernandez-Garcia; Fernando Cardona-Diaz; Carmen Maria Cortes-Salazar; Maite Asenjo-Plaza; Maria Concepcion Garcia Ruiz; Enrique Varea-Marineto; Maria Jose Banderas-Donaire; Juan Alcaide-Torres; María Isabel Queipo-Ortuño; Isabel Moreno-Indias; Mercedes Clemente-Postigo; Daniel Castellano-Castillo; Francisco J. Tinahones
18th European Congress of Endocrinology | 2016
Jose Carlos Fernandez-Garcia; Carmen Maria Cortes-Salazar
18th European Congress of Endocrinology | 2016
Jose Carlos Fernandez-Garcia; Carmen Maria Cortes-Salazar
18th European Congress of Endocrinology | 2016
Daniel Castellano-Castillo; Isabel Moreno-Indias; María Isabel Queipo-Ortuño; Jose Carlos Fernandez-Garcia; Juan Alcaide-Torres; Francisco J. Tinahones; Fernando Cardona-Diaz
18th European Congress of Endocrinology | 2016
Isabel Moreno-Indias; Lidia Sanchez-Alcoholado; Jose Carlos Fernandez-Garcia; Daniel Castellano-Castillo; Fernando Cardona-Diaz; María Isabel Queipo-Ortuño